Putin doesn’t need to be outdone by Pfizer and says Russia is about to register a 3rd Covid vaccine

A screen shows Russian President Vladimir Putin during the 15th annual year-end press conference at the World Trade Center in Moscow.

Valery Sharifulin

President Vladimir Putin said Tuesday that Russia was about to register its third vaccine against the coronavirus, according to Russian news agencies.

Putin also said that “all” Russian coronavirus vaccines were effective, the RIA reported. He didn’t seem to give any further details about the vaccine or its registration.

He said Moscow was ready to work with all other countries on vaccines, but warned against “politicizing” the process.

“I agree that such a vaccine should belong to all of humanity,” Putin said at the Shanghai Cooperation Organization summit, according to Tass News Agency. “We are ready to work with all countries, including our SCO partners.”

The comments came a day after US pharmaceuticals company Pfizer and German biotechnology BioNTech announced that preliminary results from late-stage clinical trials showed their coronavirus vaccine was 90% effective at preventing Covid-19 if no previous infections were detected were.

The news skyrocketed global stock markets and sparked cautious optimism among Western governments.

Pharmaceutical companies, health officials, and vaccine researchers at academic institutions have been trying at breakneck speed to find a coronavirus vaccine.

Pfizer’s news seems to mark a breakthrough, but the vaccine isn’t the only one in development.

Russia was the first country to register and approve a coronavirus vaccine called “Sputnik V” in August.

According to data from Johns Hopkins University, the country has the fifth highest number of coronavirus infections in the world. To date, nearly 1.8 million cases have been confirmed.

The announcement of the Russian vaccine Covid-19 in August raised concerns among some members of the international scientific community about the speed of approval – the vaccine had not yet begun Phase 3 trials – and the lack of available data to support the Russian claims The effectiveness and effectiveness of the vaccine support Safety – No results from previous studies have been published.

In September, the Russian Gamaleya Research Institute of Epidemiology and Microbiology, which developed the vaccine, published early-stage study results in The Lancet Medical Journal. However, the reliability of the data has been questioned by a group of scientists.

Russia’s vaccine developers now say that clinical trials of the third stage of the vaccine with 40,000 volunteers are underway in Russia. Studies have been announced in the United Arab Emirates, India, Venezuela and Belarus.

In mid-October, Russia announced that it had granted approval of a second coronavirus vaccine, although in this case it was approved again before significant results were published and a large-scale phase 3 study commenced, Reuters reported.

On Monday, Kirill Dmitriev, the head of the Russian sovereign wealth fund that supports the development of the Sputnik V vaccine, said Russia would publish clinical trials with preliminary efficacy data in November, Sputnik News reported.

Following Pfizer’s announcement, a representative from Russia’s Ministry of Health said Monday the Sputnik V vaccine was also more than 90% effective, Reuters reported.

Comments are closed.